Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A H Rubenstein

Showing results (11-20 of 241) with videos related to

Pageof 25
Sort By:
Lancet (London, England)|February 21, 1987
Immunosuppression in the treatment of insulin-dependent (type 1) diabetesA H Rubenstein, D Pyke
Diabetes|September 1, 1977
Circulating glucagon. Plasma profiles and metabolism in health and diseaseJ B Jaspan, A H Rubenstein
The New England Journal of Medicine|March 17, 1988
Immunosuppression for insulin-dependent diabetesK C Herold, A H Rubenstein
JAMA|September 14, 1970
Spontaneous hypoglycemia in diabetic patients with renal insuff- iciencyM B Block, A H Rubenstein
The Journal of Clinical Endocrinology and Metabolism|February 1, 1974
Metabolism of endogenous proinsulin and insulin in manJ I Starr, A H Rubenstein
The Journal of Clinical Investigation|May 1, 1973
Metabolism of proinsulin, insulin, and C-peptide in the ratA I Katz, A H Rubenstein
British Medical Journal|September 26, 1970
Reversible cerebral oedema complicating diabetic ketoacidosisA L Metzger, A H Rubenstein
Annals of Internal Medicine|September 1, 1992
New directions in the immunology of autoimmune diabetesK C Herold, A H Rubenstein
Israel Journal of Medical Sciences|October 1, 1974
Heterogeneity of circulating insulin and proinsulin in manD L Horwitz, A H Rubenstein
Diabetes|May 1, 1984
C-peptide as a measure of the secretion and hepatic extraction of insulin. Pitfalls and limitationsK S Polonsky, A H Rubenstein
Pageof 25

Showing results (11-20 of 241) with videos related to

Sort By:
Pageof 25
Lancet (London, England)|February 21, 1987
Immunosuppression in the treatment of insulin-dependent (type 1) diabetesA H Rubenstein, D Pyke
Diabetes|September 1, 1977
Circulating glucagon. Plasma profiles and metabolism in health and diseaseJ B Jaspan, A H Rubenstein
The New England Journal of Medicine|March 17, 1988
Immunosuppression for insulin-dependent diabetesK C Herold, A H Rubenstein
JAMA|September 14, 1970
Spontaneous hypoglycemia in diabetic patients with renal insuff- iciencyM B Block, A H Rubenstein
The Journal of Clinical Endocrinology and Metabolism|February 1, 1974
Metabolism of endogenous proinsulin and insulin in manJ I Starr, A H Rubenstein
The Journal of Clinical Investigation|May 1, 1973
Metabolism of proinsulin, insulin, and C-peptide in the ratA I Katz, A H Rubenstein
British Medical Journal|September 26, 1970
Reversible cerebral oedema complicating diabetic ketoacidosisA L Metzger, A H Rubenstein
Annals of Internal Medicine|September 1, 1992
New directions in the immunology of autoimmune diabetesK C Herold, A H Rubenstein
Israel Journal of Medical Sciences|October 1, 1974
Heterogeneity of circulating insulin and proinsulin in manD L Horwitz, A H Rubenstein
Diabetes|May 1, 1984
C-peptide as a measure of the secretion and hepatic extraction of insulin. Pitfalls and limitationsK S Polonsky, A H Rubenstein
Pageof 25